1. Home
  2. NWFL vs NERV Comparison

NWFL vs NERV Comparison

Compare NWFL & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Norwood Financial Corp.

NWFL

Norwood Financial Corp.

HOLD

Current Price

$31.31

Market Cap

336.1M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.74

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWFL
NERV
Founded
1870
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
336.1M
301.6M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
NWFL
NERV
Price
$31.31
$4.74
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$33.00
$10.50
AVG Volume (30 Days)
13.0K
131.3K
Earning Date
04-27-2026
05-01-2026
Dividend Yield
4.39%
N/A
EPS Growth
15150.00
N/A
EPS
0.35
N/A
Revenue
$7,999,000.00
$41,175,600.00
Revenue This Year
$34.35
N/A
Revenue Next Year
$5.55
N/A
P/E Ratio
$88.29
N/A
Revenue Growth
8.11
N/A
52 Week Low
$23.70
$1.57
52 Week High
$32.23
$12.46

Technical Indicators

Market Signals
Indicator
NWFL
NERV
Relative Strength Index (RSI) 59.97 41.02
Support Level $27.56 $3.69
Resistance Level $32.20 $5.61
Average True Range (ATR) 0.72 0.44
MACD 0.13 0.01
Stochastic Oscillator 88.04 37.98

Price Performance

Historical Comparison
NWFL
NERV

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: